The effect of tolvaptan on autosomal dominant polycystic kidney disease patients: a subgroup analysis of the Japanese patient subset from TEMPO 3:4 trial
2015 ◽
Vol 19
(5)
◽
pp. 867-877
◽
2014 ◽
Vol 64
(4)
◽
pp. 660
◽